BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30041879)

  • 1. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
    Ghasemi A; Mohammad N; Mautner J; Taghipour Karsabet M; Amani J; Ardjmand A; Vakili Z
    Vaccine; 2018 Aug; 36(34):5124-5132. PubMed ID: 30041879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice.
    Ghasemi A; Mohammad N; Mautner J; Karsabet MT; Ardjmand A; Moniri R
    Mol Immunol; 2018 Feb; 94():176-182. PubMed ID: 29324238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
    Zhou Z; Dong H; Huang Y; Yao S; Liang B; Xie Y; Long Y; Mai J; Gong S
    J Med Microbiol; 2017 Jan; 66(1):83-89. PubMed ID: 27930268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori.
    Mori J; Vranac T; Smrekar B; Cernilec M; Serbec VČ; Horvat S; Ihan A; Benčina M; Jerala R
    Vaccine; 2012 Aug; 30(40):5856-63. PubMed ID: 22819990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
    Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant.
    Chionh YT; Arulmuruganar A; Venditti E; Ng GZ; Han JX; Entwisle C; Ang CS; Colaco CA; McNulty S; Sutton P
    Vaccine; 2014 Apr; 32(20):2350-8. PubMed ID: 24625340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
    Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
    Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
    World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
    Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
    Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
    J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
    J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Protection Against
    Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
    Front Immunol; 2019; 10():1185. PubMed ID: 31191547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.